Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

7 Feb 2013 07:00

RNS Number : 3184X
Carclo plc
07 February 2013
 



7 February 2013

Carclo plc

("Carclo" or "the group")

 

Interim Management Statement

 

The board is pleased to report that the group is benefitting from a better second half trading performance, as expected.

 

In Technical Plastics, demand from a number of customers weakened in December and was slow to recover in January. Schedules have now returned to normal and February has started well. In LED Technologies, Wipac's supercar lighting business has enjoyed a solid start to its fourth quarter and the Precision Engineering division continues to perform well.

 

On 20 December 2012 we announced that volume production of touch sensors based on Conductive Inkjet Technology's ("CIT's") Fine Line Technology had commenced and that shipments of touch sensors had exceeded the minimum volume threshold specified in our agreement with Atmel Corporation ("Atmel"). There has been a delay in the Atmel managed downstream supply chain associated with the differing manufacturing requirements between ITO and XSense™ touch sensors. These manufacturing issues have now been largely resolved and all parties are confident that the production ramp-up will commence shortly. The US$10.0 million prepayment has been triggered but will not be received until full-scale production resumes and Atmel has invoiced its customer.

 

Validation of the Atmel US XSense™ facility is imminent but not yet complete, and this will reduce CIT film sales in the present quarter relative to our previous expectations. Commercially, Atmel report continuing high interest in XSense™ with a further design nomination confirmed and a promising pipeline of projects. Plans are well advanced at Atmel for further increases in manufacturing capacity in the second half of 2013.

 

We remain excited about the prospects for XSense™ and CIT especially in the next financial year and beyond.The group's financial position continues to be strong and will benefit further from the receipt of the US$10.0 million prepayment in due course.

 

As previously announced, Ian Williamson retires as Chief Executive on 27 March 2013 and Chris Malley will become Chief Executive on this date. Ian will continue to support Chris in a consultancy role concentrating on the technical and commercial development of Carclo Diagnostic Solutions.

 

- ENDS -

 

 

Enquiries:

Carclo plc

01924 268040

Ian Williamson, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat / Robert Cook

 

 

Notes to editors

 

·; Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

 

·; Approximately three fifths of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

·; Approximately two fifths of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries. Carclo is a leader in the development of high power LED lighting for supercars.

 

·; Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUQPPUPWGBQ
Date   Source Headline
27th Apr 20217:00 amRNSFull Year Trading Update
22nd Apr 20219:13 amRNSHolding(s) in Company
25th Feb 202110:32 amRNSHolding(s) in Company
24th Feb 202110:31 amRNSHolding(s) in Company
22nd Feb 202110:28 amRNSHolding(s) in Company
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.